tm logo
AIRNECFLU
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 01 Apr 2024

Last Applicant/ Owned by

Xintai 5th Rd., Xizhi Dist.

New Taipei City

TW

221

Serial Number

97125105 filed on 15th Nov 2021

Registration Number

N/A

Correspondent Address

Joe McKinney Muncy

Joe McKinney Muncy

4000 LEGATO ROAD SUITE 310

FAIRFAX VA 22033

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AIRNECFLU

Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, namely, schizophrenia, depression, atte Read More

Classification Information


Class [005]
Pharmaceutical Products


Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, hyperactivity, anxiety, bipolar disorder, and other central nervous system disorders; medicines for human purposes namely, for improving basic behavioral functioning, suicidal ideation and behavior, sensorimotor gating, pain threshold, memory and cognitive functioning and loss weight; sedatives; nervines for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS); gases for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS);nasal spray for treating respiratory tract infections caused by viruses or bacteria; oral spray for treating respiratory tract infections caused by viruses or bacteria

Mark Details


Serial Number

No 97125105

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 5454/0213TUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Apr 2024ABANDONMENT - NO USE STATEMENT FILED
01st Apr 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
29th Aug 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04th Jul 2023PUBLISHED FOR OPPOSITION
04th Jul 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14th Jun 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01st Jun 2023APPROVED FOR PUB - PRINCIPAL REGISTER
02th May 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
02th May 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
02th May 2023TEAS/EMAIL CORRESPONDENCE ENTERED